Zhiqiang Shu
Stock Analyst at Berenberg
(0.10)
# 4,125
Out of 4,829 analysts
8
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $18.35 | +41.69% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $0.74 | +1,521.40% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $100.27 | -10.24% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $0.87 | +3,348.28% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.36 | +3,207.61% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $10.18 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $0.99 | +4,642.68% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $1.36 | +3,650.00% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $18.35
Upside: +41.69%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $0.74
Upside: +1,521.40%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $100.27
Upside: -10.24%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $0.87
Upside: +3,348.28%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.36
Upside: +3,207.61%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $10.18
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $0.99
Upside: +4,642.68%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $1.36
Upside: +3,650.00%